Trial
NCT04002310
A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Macular Degeneration
Intervention
BI 754132
Why stopped
The trial was discontinued in the interests of patients considering benefit/risk balance.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-15